We are currently looking for a Full-time, 1-year contract Research Assistant II with a possibility of extension to support a national adaptive platform trial to evaluate treatments for COVID in outpatient and community settings and other projects across our lab.
- Understand the concept and advantages of adaptive platform trials over traditional randomized controlled trials
- Understand the statistical methods used in adaptive platform trials, including Bayesian methods and sequential hypothesis testing
- Identify the practical challenges associated with adaptive platform trials and learn how to address them
Date and Location
September 28-29, 2023
Chestnut Conference Centre, Toronto, ON
The APT Scientific Meeting is for Scientists, Statisticians, Clinical Project Managers, Clinical Research Advisors, Clinical Trial Directors, Early Career Researchers and Trainees.
CanTreatCOVID: Canadian Adaptive Platform Trial of Treatments for COVID in Community Settings
The study is open to adults aged 18 – 49 years with one or more chronic condition(s) or adults aged 50+ years who tested positive for COVID with symptoms starting in the last five days.
Eligible participants will
- Take a COVID medication approved by Health Canada or follow public health advice on COVID
- Complete an online diary from Day 1 to 14
- Complete a survey on Day 21, 28 and 90 and Week 36
- Receive $30 for each follow-up
Participation is voluntary.
Prospective Master’s & PhD Student
Dr. Andrew Pinto is accepting Master’s and PhD students enrolled at Institute of Health Policy, Management and Evaluation and Dalla Lana School of Public Health at the University of Toronto. Students who are interested in being supervised by Dr. Pinto should email email@example.com at least 6 weeks prior to deadlines, and provide a CV and brief letter indicating their alignment with the Lab.